ICD-11 classes
X Extension Codes
Extension codes of particular relevance to skin diseases
Histopathology
Histopathology by behaviour
Malignant tumours
Adenocarcinomas, malignant

ICD-11 Adenocarcinomas, malignant

The diagnosis has no description.

The diagnosis includes nothing.

The diagnosis excludes nothing.

Diagnosis contains 157 clarifying diagnoses:

1. XH2QZ6 Acidophil carcinoma
2. XH5LA4 Adenocarcinoid tumour
3. XH74S1 Adenocarcinoma, NOS
4. XH7QZ0 Adenocarcinoma in adenomatous polyp
5. XH2ZH8 Adenocarcinoma in adenomatous polyposis coli
6. XH9YR3 Adenocarcinoma in multiple adenomatous polyps
7. XH7QB1 Adenocarcinoma in tubulovillous adenoma
8. XH6DA5 Adenocarcinoma in villous adenoma
9. XH5RE1 Adenocarcinoma of anal glands
10. XH2ZQ0 Adenocarcinoma with mixed subtypes
11. XH0349 Adenocarcinoma, intestinal type
12. XH8B45 Solid carcinoma, NOS
13. XH8DS0 Neuroendocrine tumour, NOS
14. XH8LX8 Neuroendocrine carcinoma, low grade
15. XH55D7 Neuroendocrine carcinoma, well-differentiated
16. XH9LV8 Neuroendocrine tumor, grade 1
17. XH7NM1 Enterochromaffin cell carcinoid
18. XH0U20 Neuroendocrine carcinoma, NOS
19. XH7F73 Neuroendocrine carcinoma, moderately differentiated
20. XH24W2 Lepidic adenocarcinoma
21. XH3QM0 Minimally invasive adenocarcinoma, Non-mucinous
22. XH4302 Adenoid cystic carcinoma
23. XH2098 Minimally invasive adenocarcinoma, Mucinous
24. XH6LV9 Papillary adenocarcinoma, NOS
25. XH95U1 Villoglandular carcinoma
26. XH6QG3 Micropapillary carcinoma, NOS
27. XH4MW7 Micropapillary adenocarcinoma
28. XH7KL6 Pituitary carcinoma, NOS
29. XH6L02 Clear cell adenocarcinoma, NOS
30. XH5085 Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma
31. XH1442 MiT Family translocation carcinomas
32. XH8EN1 Succinate dehydrogenase deficient renal cell carcinoma
33. XH07X3 Alveolar adenocarcinoma
34. XH05V6 Renal cell carcinoma, NOS
35. XH3Z08 Renal cell carcinoma, unclassified
36. XH0RU3 Acquired cystic disease associated renal cell carcinoma
37. XH7K79 Tubulocystic renal cell carcinoma
38. XH1VB1 Hybrid oncocytic chromophobe tumour
39. XH3Z50 Follicular carcinoma, NOS
40. XH9508 Endometrioid adenocarcinoma, ciliated cell variant
41. XH0718 Endometrioid adenocarcinoma, secretory variant
42. XH4KH2 Adrenal cortical carcinoma
43. XH0SD2 Endometrioid adenocarcinoma, NOS
44. XH51K1 Neuroendocrine tumour, grade 2
45. XH09B7 Endometrioid cystadenocarcinoma
46. XH6KR7 Endometrioid adenofibroma, malignant
47. XH0GS9 Adenocarcinoma, endocervical type
48. XH8SF8 Islet cell adenomatosis
49. XH43E4 Perihilar cholangiocarcinoma
50. XH4BY1 Islet cell adenoma
51. XH3CU4 Villoglandular variant of endometrioid adenocarcinoma
52. XH5QV8 Pituitary blastoma
53. XH0Y80 Follicular carcinoma, encapsulated, angioinvasive
54. XH46F1 Clear cell renal cell carcinoma, NOS
55. XH9SA7 Basal cell adenocarcinoma
56. XH85C2 Endolymphatic sac tumor
57. XH4PB1 Acinar adenocarcinoma of prostate
58. XH8E54 Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)
59. XH5QW8 Neuroendocrine tumour, grade 3
60. XH1NL5 Nesidioblastoma
61. XH5XB7 Islet cell carcinoma
62. XH2ST7 Islet cell tumor, NOS
63. XH4SH8 Insulinoma, NOS
64. XH93H8 Gastrinoma
65. XH7JQ0 Parathyroid carcinoma
66. XH9LV7 Basophil carcinoma
67. XH7152 Glucagon-like peptide-producing tumour
68. XH7LW9 L-cell tumour
69. XH9ZS8 Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour
70. XH4NQ8 Glucagonoma
71. XH2PF0 Enteroglucagonoma
72. XH72E5 Vipoma
73. XH5VH0 Somatostatinoma
74. XH41P2 Endocrine tumour, functioning, NOS
75. XH7AG8 ACTH-producing tumour
76. XH60V1 Medullary thyroid carcinoma
77. XH3BU6 Bile duct cystadenocarcinoma
78. XH2MW1 Medullary carcinoma with amyloid stroma
79. XH8VU6 Poorly differentiated thyroid carcinoma
80. XH4NH4 Pituitary neuroendocrine tumour
81. XH2ZA2 Bronchial adenoma, carcinoid
82. XH5TR7 Adenocarcinoma of lung, mixed mucinous and non-mucinous
83. XH7GY6 Adenocarcinoma of lung, mucinous
84. XH2035 Bronchiolo-alveolar carcinoma, non- mucinous
85. XH6LF9 Carcinoma simplex
86. XH0XL5 Carcinoma, diffuse type
87. XH7M15 Cholangiocarcinoma
88. XH7SS7 Chromophobe carcinoma
89. XH2Q13 Clear cell adenocarcinofibroma
90. XH6YS0 Clear cell adenocarcinoma, mesonephroid
91. XH4SQ4 Collecting duct carcinoma
92. XH7QJ6 Combined hepatocellular carcinoma and cholangiocarcinoma
93. XH4KK0 Cyst-associated renal cell carcinoma
94. XH0LH8 Enterochromaffin-like cell tumour
95. XH5P16 Fetal adenocarcinoma
96. XH7TE3 Follicular adenocarcinoma, moderately differentiated
97. XH0VD1 Follicular adenocarcinoma, trabecular
98. XH8FK7 Follicular adenocarcinoma, well differentiated
99. XH3DN7 Follicular carcinoma, minimally invasive
100. XH90N9 Follicular carcinoma, oxyphilic cell
101. XH3XT5 Glycogen-rich carcinoma
102. XH4262 Goblet cell carcinoid
103. XH2EH4 Granular cell carcinoma
104. XH4T58 Hepatocellular carcinoma, clear cell type
105. XH9Q35 Hepatocellular carcinoma, fibrolamellar
106. XH0G90 Hepatocellular carcinoma, pleomorphic type
107. XH5761 Hepatocellular carcinoma, scirrhous
108. XH3T17 Hepatocellular carcinoma, spindle cell variant
109. XH6YH5 Hurthle cell adenocarcinoma
110. XH8MQ3 Hurthle cell carcinoma
111. XH8WM4 Linitis plastica
112. XH6TK0 Lipid-rich carcinoma
113. XH81N8 Merkel cell carcinoma
114. XH7019 Mixed acidophil-basophil carcinoma
115. XH8EZ3 Mixed acinar-endocrine carcinoma
116. XH74Y9 Mixed acinar-endocrine-ductal carcinoma
117. XH6H10 Mixed adenoneuroendocrine carcinoma
118. XH2AM6 Mixed cell adenocarcinoma
119. XH7CY5 Mixed ductal-endocrine carcinoma
120. XH6UP4 Mixed endocrine and exocrine adenocarcinoma
121. XH7DG7 Mixed medullary-follicular carcinoma
122. XH3340 Mixed medullary-papillary carcinoma
123. XH9LZ7 Mixed pancreatic endocrine and exocrine tumour, malignant
124. XH1108 Nonencapsulated sclerosing carcinoma
125. XH09D6 Oxyphilic adenocarcinoma
126. XH3614 Islet cell adenocarcinoma
127. XH3709 Pancreatic neuroendocrine tumor, nonfunctioning
128. XH6XY9 Pancreatobiliary-type carcinoma
129. XH1ND9 Papillary carcinoma of thyroid
130. XH85E5 Papillary carcinoma, columnar cell
131. XH0426 Papillary carcinoma, diffuse sclerosing
132. XH0Q59 Papillary carcinoma, encapsulated, of thyroid
133. XH29M4 Papillary carcinoma, follicular variant
134. XH5YT2 Papillary carcinoma, oncocytic variant
135. XH2AW7 Papillary microcarcinoma
136. XH1D07 Papillary renal cell carcinoma
137. XH4Q20 Papillotubular adenocarcinoma
138. XH1JZ0 Parietal cell carcinoma
139. XH6153 Renal cell carcinoma, chromophobe type
140. XH9DH7 Renal cell carcinoma, sarcomatoid
141. XH4FS4 Scirrhous adenocarcinoma
142. XH34G3 Solid carcinoma with mucin formation
143. XH0JE3 Superficial spreading adenocarcinoma
144. XH7EX3 Trabecular adenocarcinoma
145. XH4TA4 Tubular adenocarcinoma
146. XH1Z69 Typical carcinoid
147. XH22Z8 Carcinoma of Skene, Cowper and Littre Glands
148. XH0X20 Villous adenocarcinoma
149. XH0A57 Water-clear cell adenocarcinoma
150. XH8UE4 Adenocarcinoma, metastatic, NOS
151. XH4ZC3 Basal cell carcinoma of the prostate
152. XH4W48 Hepatocellular carcinoma, NOS
153. XH81Q9 Bronchial adenoma, cylindroid
154. XH92Y9 Thymic carcinoma with adenoid cystic carcinoma-like features
155. XH1YZ3 Cribriform carcinoma, NOS
156. XH4YG1 Cribriform comedo-type carcinoma
157. XH74B2 Serrated adenocarcinoma

The diagnosis is coded elsewhere:

• Adenomas and adenocarcinomas #38190
• Malignant tumours #40688
• Adenomas and adenocarcinomas #65415